Pure Biologics S.A.
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
PUR | WAR
Overview
Corporate Details
- ISIN(s):
- PLPRBLG00010 (+1 more)
- LEI:
- 2594002TXS19AUYHIF82
- Country:
- Poland
- Address:
- WROCŁAW LEGNICKA 48E, 54-202 WROCŁAW
- Website:
- https://purebiologics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pure Biologics S.A. is a biopharmaceutical company focused on the discovery and development of novel biological drugs and non-systemic therapies. The company utilizes its expertise in antibody and aptamer technologies to develop new therapeutic molecules. Its development portfolio primarily targets immuno-oncology and autoimmune diseases. A key element of its strategy is the focus on creating entirely new biological drugs, as opposed to generic or biosimilar alternatives, positioning itself as an innovator in the biotechnology sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-06 11:46 |
Share Issue/Capital Change
Deklaracja w przedmiocie objęcia akcji nowej emisji - Content (PL)
|
Polish | 1.0 KB | ||
| 2025-10-01 17:28 |
Pre-Annual General Meeting Information
Zmieniona treść projektów uchwał NWZ Pure Biologics S.A. zwołanego na dzień 21.…
|
Polish | 204.2 KB | ||
| 2025-10-01 17:28 |
Pre-Annual General Meeting Information
Zmieniona treść ogłoszenia o zwołaniu NWZ Pure Biologics S.A. na dzień 21.10.20…
|
Polish | 200.3 KB | ||
| 2025-10-01 17:28 |
Pre-Annual General Meeting Information
Zmiana w porządku obrad Nadzwyczajnego Walnego Zgromadzenia Pure Biologics S.A.…
|
Polish | 1.5 KB | ||
| 2025-09-30 20:01 |
Audit Report / Information
Raport niezależnego biegłego rewidenta z badania sprawozdania finansowego Pure …
|
Polish | 287.3 KB | ||
| 2025-09-30 20:01 |
Interim Report
Skrócone śródroczne sprawozdanie finansowe Pure Biologics S.A. za okres 1.01.20…
|
Polish | 4.5 MB | ||
| 2025-09-30 20:01 |
Interim Report
Jednostkowy raport półroczny Pure Biologics S.A. za okres 1.01.2025-30.06.2025
|
Polish | 2.9 MB | ||
| 2025-09-24 19:51 |
Post-Annual General Meeting Information
Treść projektów uchwał NWZ Pure Biologics S.A. zwołanego na dzień 21.10.2025
|
Polish | 201.2 KB | ||
| 2025-09-24 19:51 |
Pre-Annual General Meeting Information
Treść ogłoszenia o zwołaniu NWZ Pure Biologics S.A. na dzień 21.10.2025
|
Polish | 199.2 KB | ||
| 2025-09-24 19:51 |
Pre-Annual General Meeting Information
Informacja o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Pure Biologics S.A. w…
|
Polish | 1.3 KB | ||
| 2025-09-15 17:57 |
Share Issue/Capital Change
Podsumowanie emisji akcji serii P1 - Content (PL)
|
Polish | 4.1 KB | ||
| 2025-09-11 18:03 |
Report Publication Announcement
Zmiana terminu publikacji raportu półrocznego za I półrocze 2025 r. - Content (…
|
Polish | 863 bytes | ||
| 2025-09-10 18:43 |
Legal Proceedings Report
Wycofanie przez Zarząd wniosku o ogłoszenie upadłości Spółki - Content (PL)
|
Polish | 1.9 KB | ||
| 2025-08-27 17:34 |
Share Issue/Capital Change
Przydział akcji zwykłych na okaziciela serii P1 - Content (PL)
|
Polish | 954 bytes | ||
| 2025-07-18 15:21 |
Share Issue/Capital Change
Zawarcie umowy inwestycyjnej z ACRX Investments Limited - Content (PL)
|
Polish | 3.3 KB |
Automate Your Workflow. Get a real-time feed of all Pure Biologics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pure Biologics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
